Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Cited In for PubMed (Select 21546441)

1.

Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.

Barreto GE, Iarkov A, Moran VE.

Front Aging Neurosci. 2015 Jan 9;6:340. doi: 10.3389/fnagi.2014.00340. eCollection 2014. Review.

2.

Combined analysis of the tobacco metabolites cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine.

Kotandeniya D, Carmella SG, Ming X, Murphy SE, Hecht SS.

Anal Chem. 2015 Feb 3;87(3):1514-7. doi: 10.1021/ac504047j. Epub 2015 Jan 14.

3.

Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.

Park SL, Carmella SG, Ming X, Vielguth E, Stram DO, Le Marchand L, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):561-9. doi: 10.1158/1055-9965.EPI-14-1054. Epub 2014 Dec 26.

PMID:
25542827
4.

CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.

Wassenaar CA, Ye Y, Cai Q, Aldrich MC, Knight J, Spitz MR, Wu X, Blot WJ, Tyndale RF.

Carcinogenesis. 2015 Jan;36(1):99-103. doi: 10.1093/carcin/bgu235. Epub 2014 Nov 21.

PMID:
25416559
5.

1,3-Butadiene exposure and metabolism among Japanese American, Native Hawaiian, and White smokers.

Park SL, Kotapati S, Wilkens LR, Tiirikainen M, Murphy SE, Tretyakova N, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2240-9. doi: 10.1158/1055-9965.EPI-14-0492.

PMID:
25368399
6.

UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.

Wassenaar CA, Conti DV, Das S, Chen P, Cook EH, Ratain MJ, Benowitz NL, Tyndale RF.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):94-104. doi: 10.1158/1055-9965.EPI-14-0804. Epub 2014 Oct 2.

PMID:
25277794
7.

Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.

Bloom AJ, Hartz SM, Baker TB, Chen LS, Piper ME, Fox L, Martinez M, Hatsukami D, Johnson EO, Laurie CC, Saccone NL, Goate A, Bierut LJ.

Ann Am Thorac Soc. 2014 Sep;11(7):1003-10. doi: 10.1513/AnnalsATS.201401-010OC.

PMID:
25072098
8.

Nicotine and carcinogen exposure after water pipe smoking in hookah bars.

St Helen G, Benowitz NL, Dains KM, Havel C, Peng M, Jacob P 3rd.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1055-66. doi: 10.1158/1055-9965.EPI-13-0939. Epub 2014 May 16.

PMID:
24836469
9.

Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.

Zhu AZ, Zhou Q, Cox LS, David SP, Ahluwalia JS, Benowitz NL, Tyndale RF.

Clin Pharmacol Ther. 2014 Aug;96(2):256-65. doi: 10.1038/clpt.2014.88. Epub 2014 Apr 14.

PMID:
24733007
10.

Cotinine and tobacco-specific carcinogen exposure among nondaily smokers in a multiethnic sample.

Khariwala SS, Scheuermann TS, Berg CJ, Hayes RB, Nollen NL, Thomas JL, Guo H, Ahluwalia JS, Benowitz NL.

Nicotine Tob Res. 2014 May;16(5):600-5. doi: 10.1093/ntr/ntt194. Epub 2013 Dec 1.

11.

Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.

Zhu AZ, Zhou Q, Cox LS, Ahluwalia JS, Benowitz NL, Tyndale RF.

PLoS One. 2013 Aug 2;8(8):e70938. doi: 10.1371/journal.pone.0070938. Print 2013.

12.

Not so Cool? Menthol's discovered actions on the nicotinic receptor and its implications for nicotine addiction.

Kabbani N.

Front Pharmacol. 2013 Jul 23;4:95. doi: 10.3389/fphar.2013.00095. eCollection 2013.

13.

Smoking and prostate cancer in a multi-ethnic cohort.

Murphy AB, Akereyeni F, Nyame YA, Guy MC, Martin IK, Hollowell CM, Walker K, Kittles RA, Ahaghotu C.

Prostate. 2013 Oct;73(14):1518-28. doi: 10.1002/pros.22699. Epub 2013 Jul 3.

14.

The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.

Zhu AZ, Renner CC, Hatsukami DK, Swan GE, Lerman C, Benowitz NL, Tyndale RF.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):708-18. doi: 10.1158/1055-9965.EPI-12-1234-T. Epub 2013 Jan 31.

15.

Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Verma M, Khoury MJ, Ioannidis JP.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):189-200. doi: 10.1158/1055-9965.EPI-12-1263. Epub 2012 Dec 14. Review.

16.

Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans.

Tang D, Kryvenko ON, Wang Y, Jankowski M, Trudeau S, Rundle A, Rybicki BA.

Carcinogenesis. 2013 Jan;34(1):113-20. doi: 10.1093/carcin/bgs326. Epub 2012 Oct 12.

17.

Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.

Zhu AZ, Binnington MJ, Renner CC, Lanier AP, Hatsukami DK, Stepanov I, Watson CH, Sosnoff CS, Benowitz NL, Tyndale RF.

Carcinogenesis. 2013 Jan;34(1):93-101. doi: 10.1093/carcin/bgs306. Epub 2012 Oct 1.

18.

Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure.

St Helen G, Dempsey D, Wilson M, Jacob P 3rd, Benowitz NL.

Addiction. 2013 Mar;108(3):607-17. doi: 10.1111/j.1360-0443.2012.04077.x. Epub 2012 Nov 1.

19.

Diurnal Evening Type is Associated with Current Smoking, Nicotine Dependence and Nicotine Intake in the Population Based National FINRISK 2007 Study.

Broms U, Pennanen M, Patja K, Ollila H, Korhonen T, Kankaanpää A, Haukkala A, Tuulio-Henriksson A, Koskenvuo M, Kronholm E, Laatikainen T, Peltonen M, Partonen T, Kaprio J.

J Addict Res Ther. 2012 Jan 25;S2. pii: 002.

20.

Genome-wide meta-analyses of smoking behaviors in African Americans.

David SP, Hamidovic A, Chen GK, Bergen AW, Wessel J, Kasberger JL, Brown WM, Petruzella S, Thacker EL, Kim Y, Nalls MA, Tranah GJ, Sung YJ, Ambrosone CB, Arnett D, Bandera EV, Becker DM, Becker L, Berndt SI, Bernstein L, Blot WJ, Broeckel U, Buxbaum SG, Caporaso N, Casey G, Chanock SJ, Deming SL, Diver WR, Eaton CB, Evans DS, Evans MK, Fornage M, Franceschini N, Harris TB, Henderson BE, Hernandez DG, Hitsman B, Hu JJ, Hunt SC, Ingles SA, John EM, Kittles R, Kolb S, Kolonel LN, Le Marchand L, Liu Y, Lohman KK, McKnight B, Millikan RC, Murphy A, Neslund-Dudas C, Nyante S, Press M, Psaty BM, Rao DC, Redline S, Rodriguez-Gil JL, Rybicki BA, Signorello LB, Singleton AB, Smoller J, Snively B, Spring B, Stanford JL, Strom SS, Swan GE, Taylor KD, Thun MJ, Wilson AF, Witte JS, Yamamura Y, Yanek LR, Yu K, Zheng W, Ziegler RG, Zonderman AB, Jorgenson E, Haiman CA, Furberg H.

Transl Psychiatry. 2012 May 22;2:e119. doi: 10.1038/tp.2012.41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk